MTBC - MTBC, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
4.6200
-0.0700 (-1.49%)
At close: 3:56PM EDT
Stock chart is not supported by your current browser
Previous Close4.6900
Open4.6600
Bid0.0000 x 1400
Ask0.0000 x 800
Day's Range4.5900 - 4.7000
52 Week Range3.2500 - 5.6500
Volume20,690
Avg. Volume54,034
Market Cap55.57M
Beta (3Y Monthly)1.69
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • How Much Of MTBC, Inc. (NASDAQ:MTBC) Do Insiders Own?
    Simply Wall St.18 days ago

    How Much Of MTBC, Inc. (NASDAQ:MTBC) Do Insiders Own?

    A look at the shareholders of MTBC, Inc. (NASDAQ:MTBC) can tell us which group is most powerful. Insiders often own a...

  • Thomson Reuters StreetEvents2 months ago

    Edited Transcript of MTBC earnings conference call or presentation 8-May-19 12:30pm GMT

    Q1 2019 MTBC Inc Earnings Call

  • Is MTBC, Inc. (NASDAQ:MTBC) A Volatile Stock?
    Simply Wall St.2 months ago

    Is MTBC, Inc. (NASDAQ:MTBC) A Volatile Stock?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...

  • Zacks Small Cap Research2 months ago

    MTBC: Revenue Growth and Synergies Results in Record Adjusted EBITDA. 2019 Guidance Affirmed

    MTBC, Inc (MTBC) reported financial results for their first quarter 2019 and provided a business update. As a reminder, financial performance immediately benefitted from the transaction, which included revenue setting record highs in Q3 and two of the three acquired business segments, namely Practice Management and the GPO, adding to profitability in that period. Particularly noteworthy (given that this metric is used to value EHR / RCM companies) is that adjusted EBITDA came in at the third best in history in Q4’18 and at an all-time high in Q1’19.

  • Zacks Small Cap Research4 months ago

    MTBC: Orion Synergies Could Double Adjusted EBITDA in 2019

    MTBC, Inc. (MTBC) reported financial results for their fourth quarter 2018 and provided a business update. Financial performance immediately benefitted from the transaction, which included revenue setting record highs in Q3 and two of the three acquired business segments, namely Practice Management and the GPO, adding to profitability in that period. Meanwhile, their initial 2019 guidance for revenue growth of at least 20%, which was announced in a January 2019 shareholder letter, has already been adjusted – to growth between 25% and 29%.

  • Thomson Reuters StreetEvents4 months ago

    Edited Transcript of MTBC earnings conference call or presentation 20-Mar-19 12:30pm GMT

    Q4 2018 MTBC Inc Earnings Call

  • Have Insiders Been Selling Medical Transcription Billing, Corp. (NASDAQ:MTBC) Shares?
    Simply Wall St.7 months ago

    Have Insiders Been Selling Medical Transcription Billing, Corp. (NASDAQ:MTBC) Shares?

    We often see insiders buying up shares in companies that perform well over the long term. On the other hand, we'd be remiss not to mention that insider sales have Read More...

  • Investopedia8 months ago

    3 Small Stocks Ready for Big Gains

    Accumulation is close to an all-time high, signaling strong speculative interest. A cup and handle breakout would yield an impressive measured move target near $9.50, which is close to a 2015 breakdown into single digits.

  • Thomson Reuters StreetEvents8 months ago

    Edited Transcript of MTBC earnings conference call or presentation 7-Nov-18 1:30pm GMT

    Q3 2018 Medical Transcription Billing Corp Earnings Call

  • Zacks Small Cap Research8 months ago

    MTBC: Q3 Update: Orion Doubles MTBC s Revenue, Already Generating Positive Adj EBITDA

    Medical Transcription Billing Corp (MTBC) reported financial results for their third quarter 2018 and provided a business update. Financial performance is already benefitting from the transaction with Q3 setting new record highs in revenue, revenue growth and consecutive quarters (i.e.

  • Investopedia9 months ago

    Penny Stocks to Buy Using Technical Analysis for November 2018

    Penny stocks got battered and bruised during the month of October, undermined by a broad-based retreat that dropped the Russell 2000 small-cap index to an eight-month low. The broad market could post new lows in early November, but a profitable relief rally should unfold in coming weeks, favoring dip trades on penny stocks that have held technical support levels through the maelstrom. This month's penny stock list includes several of these plays, but it's important to think and act defensively, placing stop losses immediately after entry. Penny Stock Picks to Buy Using Technical Analysis for November 1.

  • Simply Wall St.9 months ago

    Should You Have Medical Transcription Billing Corp’s (NASDAQ:MTBC) In Your Portfolio?

    If you’re interested in Medical Transcription Billing Corp (NASDAQ:MTBC), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock Read More...

  • Investopedia10 months ago

    Penny Stocks to Buy Using Technical Analysis for October 2018

    Blue chips led broad price action in September, lifting the S&P 500 and the Dow Jones Industrial Average to bull market highs while small cap indices such as the Russell 2000 pulled back in shallow declines. Penny and low-priced stocks held up well during the month despite this headwind, with traders scooping up junior energy plays in reaction to a surging crude oil market. Penny stock buyers have taken notice, lifting the shares of low-priced American oil and gas companies still reeling from the group's historic decline into 2016.

  • Investopedia11 months ago

    Penny Stocks to Buy Using Technical Analysis for September 2018

    Penny stocks approaching key price levels dominate September's technical analysis buy list, telling interested traders to build watch lists and track progress while awaiting fruitful buying signals or reversals that break bullish patterns. First, establish the price level that is likely to attract strong buying interest. Second, look for the price level that is likely to attract strong selling interest.

  • Zacks Small Cap Research11 months ago

    MTBC: Updated Orion Guidance Prompts Significant Upward Model Revisions, Moves PT to $10/share

    This upwardly revised guidance is well ahead of the $42.3M in revenue and $3.6M in adjusted EBITDA that we had been modeling for 2018 following the announced-close of the Orion acquisition in early July. Updates to our model have resulted in calculated fair value of MTBC common stock moving from $7.10/share (previously) to $10.0/share (currently). In fact, excluding Q4 ’16 which benefitted from one-time sales following close of the MediGain acquisition, Q1 and Q2 2018 set new quarterly revenue records.

  • Thomson Reuters StreetEvents11 months ago

    Edited Transcript of MTBC earnings conference call or presentation 8-Aug-18 12:30pm GMT

    Q2 2018 Medical Transcription Billing Corp Earnings Call